PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm AGM Presentation, page-113

  1. 2,840 Posts.
    lightbulb Created with Sketch. 714
    I went to the AGM with some doubt after the recent goings and comings. It literally was a make or break for my continuing investment in PAR.
    I was pleased to hear the reasoning and genuine response from PR as well as some constructive answers to question during and after.
    I pulled a sell order on a parcel at the end of the meeting.

    I also had the pleasure of meeting a few HC contributors in person including Mozz. and Hottod.
    I am going to have to work some extra hours this week to cover the time but I reckon it was worth it.
    IMO the next problem to solve after approvals is the application at scale. If word of mouth gets out once this is on the market then off label prescriptions will go nuts.

    This is a self-injectable drug called ozempic (and its alternative Wegovy) that is used to treat insulin sensitivity and obesity for type two diabetes and co-morbid obese patients. The demand outstripped supply as soon as social media started buzzing with the effect on weight loss.
    https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/ozempic-semaglutide-shortage
    https://apps.tga.gov.au/shortages/Search/Details/Semaglutide
    https://www.theaustralian.com.au/the-oz/news/longterm-harm-for-diabetics-unable-to-access-medication/news-story/fdc23d4445d2c6523ad8943c410b4438

    The problem was exacerbated by a filling plant non-conformance for GMP(Good Manufacturing Practices) issued by the FDA
    https://endpts.com/fda-concerns-at-contractor-catalent-site-spurred-on-shortages-of-novo-nordisks-semaglutide-report/

    The filling is done at a specialist plant with the drug supplied in concentrate form (API).

    PR noted in response to the question around supply during discussions after the formal meeting, that PAR are planning and preparing with the supplier for delivery ramp-up and establish scalable supply quickly will be a high priority.
    Last edited by strangelogic: 05/12/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.